Press Release Contact

Press release:
Advancing Cancer Immunotherapy in Collaboration with Amsterdam UMC Cancer Center; Creating a “NEWCO”: Nasdaq: RENB
May 24, 2024, 14:48 GMT

For questions about this press release, please contact the person or organization listed below.

The Hon. Mark Dybul, MD, CEO
Renovaro Biosciences Inc
+1 732-780-5036
Visit us on social media:
X
LinkedIn